Drawing for JAZZ PHARMACEUTICALS

USPTO serial 86661335

JAZZ PHARMACEUTICALS

Reviewed by CopyMark Law Group

Reg. 5071067Status 800Renewal
Filing date
Status date
Registration date
Nov 1, 2016
Examiner
MONINGHOFF, KIM TERESA
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with JAZZ PHARMACEUTICALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $850

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael Olsen

Michael Olsen Winthrop & Weinstine, P.A.225 SOUTH 6TH STREET, SUITE 3500MINNEAPOLIS, MN 55402United States

Goods and services

ClassDescriptionStatusFirst use
005House mark for a line of pharmaceuticals for the treatment and prevention of cancer, psychiatric diseases and disorders, central nervous system conditions, pain, sleep disorders, narcolepsy, schizophrenia, and for use in oncology and hematology; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations acting on the central nervous system; pain relief medication; pharmaceutical preparations for use in the treatment and/or management of sleep disorders; pharmaceutical preparations for the treatment of narcolepsy; pharmaceutical preparations for the treatment of schizophrenia; pharmaceutical preparations for use in oncology and hematologyACTIVESep 8, 2004

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 26, 2026NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Aug 26, 2026RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Aug 26, 202689AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Aug 26, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 2, 2026E89RTEAS SECTION 8 & 9 RECEIVED—
Nov 11, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 11, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 11, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 11, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 11, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Nov 1, 2025REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Apr 9, 2023NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Apr 9, 2023C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Apr 9, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 29, 2022E815TEAS SECTION 8 & 15 RECEIVED—
Nov 1, 2021REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
May 26, 2021ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jun 15, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 15, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 23, 2018CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 23, 2018COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Nov 1, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 16, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 16, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 27, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 14, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 14, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Jul 14, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 14, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 14, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 4, 2016GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Apr 4, 2016GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 4, 2016CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 29, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 28, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 28, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 28, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 28, 2015GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Sep 28, 2015GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Sep 28, 2015CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Sep 22, 2015DOCKASSIGNED TO EXAMINER—
Jun 24, 2015ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jun 17, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 16, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance